Total Payments
$1,442
2021 Payments
$183.02
Companies
11
Transactions
26
Medicare Patients
394
Medicare Billing
$45,665
Payment Breakdown by Category
Food & Beverage$1,442 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,442 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $351.10 | 6 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $275.52 | 7 | $0 (2021) |
| PORTOLA PHARMACEUTICALS, INC. | $130.81 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $127.47 | 3 | $0 (2021) |
| La Jolla Pharmaceutical Company | $121.69 | 2 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $114.02 | 2 | $0 (2017) |
| Melinta Therapeutics, Inc. | $92.63 | 1 | $0 (2018) |
| BTG INTERNATIONAL, INC. | $89.32 | 1 | $0 (2020) |
| Chiesi USA, Inc. | $60.39 | 1 | $0 (2018) |
| PFIZER INC. | $47.75 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $183.02 | 6 | AstraZeneca Pharmaceuticals LP ($144.45) |
| 2020 | $226.62 | 5 | BTG INTERNATIONAL, INC. ($89.32) |
| 2019 | $545.95 | 7 | PORTOLA PHARMACEUTICALS, INC. ($130.81) |
| 2018 | $302.53 | 4 | Melinta Therapeutics, Inc. ($92.63) |
| 2017 | $184.26 | 4 | Valeant Pharmaceuticals North America LLC ($114.02) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: Cardiovascular | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $118.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/16/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/10/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Gastroenterology | ||||||
| 03/01/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: Cardiovascular | ||||||
| 01/29/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Food and Beverage | Cash or cash equivalent | $89.32 | General |
| Category: ANTI-VENOM | ||||||
| 01/09/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $78.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 11/14/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $47.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $107.68 | General |
| Category: Cardiovascular | ||||||
| 03/25/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.39 | General |
| Category: Cardiovascular | ||||||
| 02/13/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $130.81 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 09/13/2018 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $60.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2018 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | Cash or cash equivalent | $92.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $61.74 | General |
| Category: Cardiovascular | ||||||
| 03/08/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/07/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.75 | General |
| Category: Cardiovascular | ||||||
| 08/16/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 63 | 64 | $27,028 | $7,979 |
| 2022 | 2 | 63 | 64 | $25,546 | $7,899 |
| 2021 | 3 | 92 | 94 | $93,077 | $10,541 |
| 2020 | 3 | 176 | 179 | $245,418 | $19,246 |
Total Patients
394
Total Services
401
Medicare Billing
$45,665
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 46 | 47 | $21,391 | $6,328 | 29.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 17 | 17 | $5,637 | $1,651 | 29.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 44 | 45 | $19,782 | $6,207 | 31.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 19 | 19 | $5,764 | $1,692 | 29.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 50 | 51 | $64,696 | $7,321 | 11.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 20 | 21 | $17,298 | $2,014 | 11.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 22 | 22 | $11,083 | $1,206 | 10.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 97 | 98 | $172,802 | $13,570 | 7.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 38 | 39 | $44,497 | $3,681 | 8.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 41 | 42 | $28,119 | $1,994 | 7.1% |
About Dr. Ruby Hoang, DO
Dr. Ruby Hoang, DO is a Emergency Medicine healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1770976623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruby Hoang, DO has received a total of $1,442 in payments from pharmaceutical and medical device companies, with $183.02 received in 2021. These payments were reported across 26 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,442).
As a Medicare-enrolled provider, Hoang has provided services to 394 Medicare beneficiaries, totaling 401 services with total Medicare billing of $45,665. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, Medical Toxicology
- Location Portland, OR
- Active Since 03/16/2015
- Last Updated 06/03/2021
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1770976623
Products in Payments
- ELIQUIS (Drug) $323.27
- LOKELMA (Drug) $263.33
- ANDEXXA (Biological) $130.81
- RELISTOR (Drug) $127.47
- GIAPREZA (Drug) $121.69
- XIFAXAN (Drug) $114.02
- Orbactiv (Drug) $92.63
- CROFAB (Drug) $89.32
- BRILINTA (Drug) $87.77
- CLEVIPREX (Drug) $60.39
- XARELTO (Drug) $31.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Portland
Andrew Goldberg, M.d, M.D
Emergency Medicine — Payments: $40,023
Emergency Medicine $40,023
Enoch Huang, Md, MD
Emergency Medicine — Payments: $2,378
Emergency Medicine $2,378
Dr. Irvan Bubic, Md, MD
Emergency Medicine — Payments: $1,577
Emergency Medicine $1,577
Christine Ren, Md, MD
Emergency Medicine — Payments: $1,547
Emergency Medicine $1,547
Matthew Noland, M.d, M.D
Emergency Medicine — Payments: $1,540
Emergency Medicine $1,540
Rachel Bengtzen, M.d, M.D
Emergency Medicine — Payments: $1,148
Emergency Medicine $1,148